|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.93 USD | -3.71% |
|
-0.35% | -1.33% |
| 07-06 | European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading | MT |
| 07-03 | BioNTech Said to Scout Potential Buyers for German Sites | MT |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 20,803 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 6.7% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 9,951 | 11,522 | 10,727 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | -19.46% | 15.79% | -6.9% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -18.7x | -18.4x | -21x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.15x | 1.27x | 1.36x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | 2.97x | -11.99x | 1.7x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 9.61x | 9.33x | 8.25x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 4.59x | 5.17x | 4.25x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -8.02x | -8.94x | -11x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -6.59x | -7.55x | -8.6x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -6.4x | -9.22x | -13.3x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -15.6% | -10.8% | -7.51% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -4.404 | -4.472 | -3.919 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 2,166 | 2,231 | 2,523 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,240 | -1,289 | -977 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,511 | -1,526 | -1,247 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,051 | -1,165 | -959 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -10,852 | -9,281 | -10,076 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 82.26 | 82.26 | 82.26 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 252,884 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -18.68x | 4.59x | -8.02x | -.--% | 23.75B | |
| 35.05x | 8.83x | 27.39x | 0.05% | 57.73B | |
| 20.57x | 6.33x | 13.71x | 1.47% | 54.69B | |
| -42.24x | 13.99x | -40.8x | -.--% | 24.18B | |
| 24.71x | 4.89x | 12.71x | -.--% | 19.82B | |
| 23.97x | 4.73x | 15.69x | -.--% | 17.14B | |
| 50.04x | 20.37x | 54.66x | 0.06% | 16.75B | |
| -546.55x | 37.62x | -4194.16x | -.--% | 15.57B | |
| 17.46x | 5.07x | 11.84x | -.--% | 13.96B | |
| -75.94x | 7.81x | -70.02x | -.--% | 12.21B | |
| Average | -51.16x | 11.42x | -417.70x | 0.16% | 25.58B | |
| Weighted average by Cap. | -22.55x | 10.06x | -247.79x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- Valuation BioNTech SE
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
